These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Srinivas TR; Schold JD; Womer KL; Kaplan B; Howard RJ; Bucci CM; Meier-Kriesche HU Clin J Am Soc Nephrol; 2006 Mar; 1(2):323-6. PubMed ID: 17699223 [TBL] [Abstract][Full Text] [Related]
24. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Dong BJ Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445 [TBL] [Abstract][Full Text] [Related]
25. Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients. Sharma AK; Masterson R; Holt SG; Tan SJ; Hughes PD; Chu M; Jayadeva P; Toussaint ND Nephrology (Carlton); 2016 Jan; 21(1):46-54. PubMed ID: 26072678 [TBL] [Abstract][Full Text] [Related]
26. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients. Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632 [TBL] [Abstract][Full Text] [Related]
27. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845 [TBL] [Abstract][Full Text] [Related]
29. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927 [TBL] [Abstract][Full Text] [Related]
30. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Schwarz A; Merkel S; Leitolf H; Haller H Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318 [TBL] [Abstract][Full Text] [Related]
31. Cinacalcet hydrochloride for the treatment of hyperparathyroidism. Verheyen N; Pilz S; Eller K; Kienreich K; Fahrleitner-Pammer A; Pieske B; Ritz E; Tomaschitz A Expert Opin Pharmacother; 2013 Apr; 14(6):793-806. PubMed ID: 23452174 [TBL] [Abstract][Full Text] [Related]
33. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917 [TBL] [Abstract][Full Text] [Related]
34. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients. Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487 [TBL] [Abstract][Full Text] [Related]
35. Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B). Debelle F; Meeus G; Dratwa M; Maes B; Vanholder R; Albert A; Schutyser E; Jadoul M Acta Clin Belg; 2013; 68(4):275-81. PubMed ID: 24455797 [TBL] [Abstract][Full Text] [Related]
36. Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands. Picazo Sánchez M; Cuxart Pérez M; Sans Lorman R; Sardà Borroy C Nefrologia; 2011; 31(1):126-7. PubMed ID: 21270934 [No Abstract] [Full Text] [Related]
37. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation]. Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884 [TBL] [Abstract][Full Text] [Related]
38. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. Shoback DM; Bilezikian JP; Turner SA; McCary LC; Guo MD; Peacock M J Clin Endocrinol Metab; 2003 Dec; 88(12):5644-9. PubMed ID: 14671147 [TBL] [Abstract][Full Text] [Related]
39. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930 [TBL] [Abstract][Full Text] [Related]
40. A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Evenepoel P; Cooper K; Holdaas H; Messa P; Mourad G; Olgaard K; Rutkowski B; Schaefer H; Deng H; Torregrosa JV; Wuthrich RP; Yue S Am J Transplant; 2014 Nov; 14(11):2545-55. PubMed ID: 25225081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]